annual EBITDA:
$583.00M+$225.00M(+62.85%)Summary
- As of today (May 29, 2025), NBIX annual EBITDA is $583.00 million, with the most recent change of +$225.00 million (+62.85%) on December 31, 2024.
- During the last 3 years, NBIX annual EBITDA has risen by +$444.90 million (+322.16%).
- NBIX annual EBITDA is now at all-time high.
Performance
NBIX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$31.30M-$150.40M(-82.77%)Summary
- As of today (May 29, 2025), NBIX quarterly EBITDA is $31.30 million, with the most recent change of -$150.40 million (-82.77%) on March 31, 2025.
- Over the past year, NBIX quarterly EBITDA has dropped by -$80.20 million (-71.93%).
- NBIX quarterly EBITDA is now -83.64% below its all-time high of $191.30 million, reached on September 30, 2024.
Performance
NBIX quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$559.50M-$80.20M(-12.54%)Summary
- As of today (May 29, 2025), NBIX TTM EBITDA is $559.50 million, with the most recent change of -$80.20 million (-12.54%) on March 31, 2025.
- Over the past year, NBIX TTM EBITDA has increased by +$66.60 million (+13.51%).
- NBIX TTM EBITDA is now -12.54% below its all-time high of $639.70 million, reached on December 31, 2024.
Performance
NBIX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
NBIX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +62.9% | -71.9% | +13.5% |
| 3 y3 years | +322.2% | +14.7% | +332.7% |
| 5 y5 years | +578.7% | -36.4% | +145.2% |
NBIX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +322.2% | -83.6% | +132.2% | -12.5% | +1121.6% |
| 5 y | 5-year | at high | +578.7% | -83.6% | +132.2% | -12.5% | +1121.6% |
| alltime | all time | at high | +387.4% | -83.6% | +124.8% | -12.5% | +362.5% |
NBIX EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $31.30M(-82.8%) | $559.50M(-12.5%) |
| Dec 2024 | $583.00M(+62.8%) | $181.70M(-5.0%) | $639.70M(+4.2%) |
| Sep 2024 | - | $191.30M(+23.3%) | $614.00M(+7.8%) |
| Jun 2024 | - | $155.20M(+39.2%) | $569.40M(+15.5%) |
| Mar 2024 | - | $111.50M(-28.5%) | $492.90M(+73.4%) |
| Dec 2023 | $358.00M(+51.3%) | $156.00M(+6.3%) | $284.20M(+1.6%) |
| Sep 2023 | - | $146.70M(+86.4%) | $279.60M(+18.5%) |
| Jun 2023 | - | $78.70M(-181.0%) | $236.00M(+68.5%) |
| Mar 2023 | - | -$97.20M(-164.2%) | $140.10M(-47.1%) |
| Dec 2022 | $236.60M(+71.3%) | $151.40M(+46.8%) | $264.60M(+142.8%) |
| Sep 2022 | - | $103.10M(-699.4%) | $109.00M(+138.0%) |
| Jun 2022 | - | -$17.20M(-163.0%) | $45.80M(-64.6%) |
| Mar 2022 | - | $27.30M(-750.0%) | $129.30M(-6.4%) |
| Dec 2021 | $138.10M(-6.8%) | -$4.20M(-110.5%) | $138.10M(-28.8%) |
| Sep 2021 | - | $39.90M(-39.8%) | $194.00M(+80.1%) |
| Jun 2021 | - | $66.30M(+83.7%) | $107.70M(-20.2%) |
| Mar 2021 | - | $36.10M(-30.2%) | $135.00M(-8.8%) |
| Dec 2020 | $148.10M(+72.4%) | $51.70M(-211.4%) | $148.10M(+2.0%) |
| Sep 2020 | - | -$46.40M(-149.6%) | $145.20M(-44.2%) |
| Jun 2020 | - | $93.60M(+90.2%) | $260.00M(+13.9%) |
| Mar 2020 | - | $49.20M(+0.8%) | $228.20M(+165.7%) |
| Dec 2019 | $85.90M(+52.6%) | $48.80M(-28.7%) | $85.90M(+32.5%) |
| Sep 2019 | - | $68.40M(+10.7%) | $64.85M(+15.9%) |
| Jun 2019 | - | $61.80M(-166.4%) | $55.97M(-1810.5%) |
| Mar 2019 | - | -$93.10M(-435.5%) | -$3.27M(-105.8%) |
| Dec 2018 | $56.30M(-146.7%) | $27.75M(-53.4%) | $56.30M(+29.2%) |
| Sep 2018 | - | $59.52M(+2223.9%) | $43.57M(-327.9%) |
| Jun 2018 | - | $2.56M(-107.6%) | -$19.12M(-74.9%) |
| Mar 2018 | - | -$33.53M(-323.2%) | -$76.31M(-36.7%) |
| Dec 2017 | -$120.62M(-13.6%) | $15.02M(-573.5%) | -$120.62M(-32.9%) |
| Sep 2017 | - | -$3.17M(-94.2%) | -$179.85M(-15.6%) |
| Jun 2017 | - | -$54.63M(-29.8%) | -$213.16M(+7.4%) |
| Mar 2017 | - | -$77.84M(+76.0%) | -$198.49M(+40.5%) |
| Dec 2016 | -$139.64M(+58.8%) | -$44.21M(+21.2%) | -$141.23M(+15.6%) |
| Sep 2016 | - | -$36.48M(-8.7%) | -$122.22M(+0.7%) |
| Jun 2016 | - | -$39.96M(+94.1%) | -$121.34M(+14.0%) |
| Mar 2016 | - | -$20.58M(-18.3%) | -$106.46M(+21.1%) |
| Dec 2015 | -$87.92M(+38.3%) | -$25.20M(-29.2%) | -$87.92M(+6.0%) |
| Sep 2015 | - | -$35.60M(+42.0%) | -$82.96M(+29.6%) |
| Jun 2015 | - | -$25.07M(+1126.6%) | -$64.00M(+20.6%) |
| Mar 2015 | - | -$2.04M(-89.9%) | -$53.08M(-16.5%) |
| Dec 2014 | -$63.58M(+29.7%) | -$20.24M(+21.7%) | -$63.58M(+16.2%) |
| Sep 2014 | - | -$16.64M(+17.6%) | -$54.71M(+9.6%) |
| Jun 2014 | - | -$14.15M(+12.8%) | -$49.91M(+2.4%) |
| Mar 2014 | - | -$12.55M(+10.3%) | -$48.75M(-0.5%) |
| Dec 2013 | -$49.01M(-2428.1%) | -$11.37M(-3.9%) | -$49.01M(+69.7%) |
| Sep 2013 | - | -$11.84M(-8.9%) | -$28.88M(+38.6%) |
| Jun 2013 | - | -$12.99M(+1.5%) | -$20.84M(+130.1%) |
| Mar 2013 | - | -$12.80M(-246.2%) | -$9.05M(-530.2%) |
| Dec 2012 | $2.10M(-93.9%) | $8.76M(-330.5%) | $2.10M(-134.7%) |
| Sep 2012 | - | -$3.80M(+212.9%) | -$6.06M(-121.4%) |
| Jun 2012 | - | -$1.21M(-26.0%) | $28.31M(-8.1%) |
| Mar 2012 | - | -$1.64M(-378.4%) | $30.80M(-11.0%) |
| Dec 2011 | $34.62M(-381.8%) | $589.00K(-98.1%) | $34.62M(+1.2%) |
| Sep 2011 | - | $30.58M(+2307.7%) | $34.20M(+431.6%) |
| Jun 2011 | - | $1.27M(-41.7%) | $6.43M(-1857.9%) |
| Mar 2011 | - | $2.18M(+1138.1%) | -$366.00K(-97.0%) |
| Dec 2010 | -$12.29M | $176.00K(-93.7%) | -$12.29M(-49.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2010 | - | $2.81M(-150.8%) | -$24.17M(-32.6%) |
| Jun 2010 | - | -$5.53M(-43.2%) | -$35.86M(-19.1%) |
| Mar 2010 | - | -$9.74M(-16.8%) | -$44.35M(-7.5%) |
| Dec 2009 | -$47.93M(-35.2%) | -$11.71M(+32.0%) | -$47.93M(-19.6%) |
| Sep 2009 | - | -$8.88M(-36.7%) | -$59.66M(-7.5%) |
| Jun 2009 | - | -$14.02M(+5.2%) | -$64.51M(-6.0%) |
| Mar 2009 | - | -$13.33M(-43.1%) | -$68.61M(-7.3%) |
| Dec 2008 | -$73.98M(-63.5%) | -$23.43M(+70.6%) | -$73.98M(-58.2%) |
| Sep 2008 | - | -$13.73M(-24.2%) | -$176.97M(-6.8%) |
| Jun 2008 | - | -$18.12M(-3.1%) | -$189.85M(-3.5%) |
| Mar 2008 | - | -$18.70M(-85.2%) | -$196.82M(-3.0%) |
| Dec 2007 | -$202.84M(+97.4%) | -$126.43M(+375.0%) | -$202.84M(+125.1%) |
| Sep 2007 | - | -$26.61M(+6.1%) | -$90.09M(-10.8%) |
| Jun 2007 | - | -$25.08M(+1.5%) | -$101.04M(-1.5%) |
| Mar 2007 | - | -$24.71M(+80.6%) | -$102.54M(-0.2%) |
| Dec 2006 | -$102.75M(+586.0%) | -$13.68M(-63.6%) | -$102.75M(-7.5%) |
| Sep 2006 | - | -$37.56M(+41.4%) | -$111.06M(+142.3%) |
| Jun 2006 | - | -$26.57M(+6.6%) | -$45.83M(+99.2%) |
| Mar 2006 | - | -$24.93M(+13.4%) | -$23.00M(+53.6%) |
| Dec 2005 | -$14.98M(-66.9%) | -$21.99M(-179.5%) | -$14.98M(+25.9%) |
| Sep 2005 | - | $27.66M(-838.3%) | -$11.89M(-70.6%) |
| Jun 2005 | - | -$3.75M(-77.8%) | -$40.50M(-16.8%) |
| Mar 2005 | - | -$16.91M(-10.6%) | -$48.67M(+7.6%) |
| Dec 2004 | -$45.25M(-17.9%) | -$18.91M(+1913.4%) | -$45.25M(+5.4%) |
| Sep 2004 | - | -$939.00K(-92.1%) | -$42.92M(-21.3%) |
| Jun 2004 | - | -$11.92M(-11.6%) | -$54.54M(+0.8%) |
| Mar 2004 | - | -$13.49M(-18.6%) | -$54.10M(-1.8%) |
| Dec 2003 | -$55.09M(-45.2%) | -$16.57M(+32.0%) | -$55.09M(-30.2%) |
| Sep 2003 | - | -$12.56M(+9.4%) | -$78.89M(-10.4%) |
| Jun 2003 | - | -$11.48M(-20.7%) | -$88.05M(-10.0%) |
| Mar 2003 | - | -$14.49M(-64.1%) | -$97.88M(-2.6%) |
| Dec 2002 | -$100.52M(+143.8%) | -$40.36M(+85.9%) | -$100.52M(+34.3%) |
| Sep 2002 | - | -$21.72M(+1.9%) | -$74.83M(+46.1%) |
| Jun 2002 | - | -$21.32M(+24.5%) | -$51.23M(+14.2%) |
| Mar 2002 | - | -$17.12M(+16.7%) | -$44.87M(+8.8%) |
| Dec 2001 | -$41.23M(+23.4%) | -$14.67M(-880.4%) | -$41.23M(+10.6%) |
| Sep 2001 | - | $1.88M(-112.6%) | -$37.29M(-22.8%) |
| Jun 2001 | - | -$14.95M(+10.9%) | -$48.29M(+20.2%) |
| Mar 2001 | - | -$13.49M(+25.7%) | -$40.18M(+20.3%) |
| Dec 2000 | -$33.40M(+87.7%) | -$10.73M(+17.6%) | -$33.40M(+23.4%) |
| Sep 2000 | - | -$9.12M(+33.3%) | -$27.07M(+20.6%) |
| Jun 2000 | - | -$6.84M(+2.0%) | -$22.45M(+9.5%) |
| Mar 2000 | - | -$6.71M(+52.4%) | -$20.50M(+15.9%) |
| Dec 1999 | -$17.80M(+66.4%) | -$4.40M(-2.2%) | -$17.69M(+6.6%) |
| Sep 1999 | - | -$4.50M(-8.0%) | -$16.59M(+12.9%) |
| Jun 1999 | - | -$4.89M(+25.4%) | -$14.69M(+14.8%) |
| Mar 1999 | - | -$3.90M(+18.2%) | -$12.80M(+17.4%) |
| Dec 1998 | -$10.70M(-694.4%) | -$3.30M(+26.9%) | -$10.90M(+28.2%) |
| Sep 1998 | - | -$2.60M(-13.3%) | -$8.50M(+41.7%) |
| Jun 1998 | - | -$3.00M(+50.0%) | -$6.00M(+71.4%) |
| Mar 1998 | - | -$2.00M(+122.2%) | -$3.50M(-284.2%) |
| Dec 1997 | $1.80M(-53.8%) | -$900.00K(+800.0%) | $1.90M(-70.3%) |
| Sep 1997 | - | -$100.00K(-80.0%) | $6.40M(+20.8%) |
| Jun 1997 | - | -$500.00K(-114.7%) | $5.30M(-27.4%) |
| Mar 1997 | - | $3.40M(-5.6%) | $7.30M(+87.2%) |
| Dec 1996 | $3.90M | $3.60M(-400.0%) | $3.90M(+1200.0%) |
| Sep 1996 | - | -$1.20M(-180.0%) | $300.00K(-80.0%) |
| Jun 1996 | - | $1.50M(>+9900.0%) | $1.50M(>+9900.0%) |
| Mar 1996 | - | $0.00 | $0.00 |
FAQ
- What is Neurocrine Biosciences annual EBITDA?
- What is the all time high annual EBITDA for Neurocrine Biosciences?
- What is Neurocrine Biosciences annual EBITDA year-on-year change?
- What is Neurocrine Biosciences quarterly EBITDA?
- What is the all time high quarterly EBITDA for Neurocrine Biosciences?
- What is Neurocrine Biosciences quarterly EBITDA year-on-year change?
- What is Neurocrine Biosciences TTM EBITDA?
- What is the all time high TTM EBITDA for Neurocrine Biosciences?
- What is Neurocrine Biosciences TTM EBITDA year-on-year change?
What is Neurocrine Biosciences annual EBITDA?
The current annual EBITDA of NBIX is $583.00M
What is the all time high annual EBITDA for Neurocrine Biosciences?
Neurocrine Biosciences all-time high annual EBITDA is $583.00M
What is Neurocrine Biosciences annual EBITDA year-on-year change?
Over the past year, NBIX annual EBITDA has changed by +$225.00M (+62.85%)
What is Neurocrine Biosciences quarterly EBITDA?
The current quarterly EBITDA of NBIX is $31.30M
What is the all time high quarterly EBITDA for Neurocrine Biosciences?
Neurocrine Biosciences all-time high quarterly EBITDA is $191.30M
What is Neurocrine Biosciences quarterly EBITDA year-on-year change?
Over the past year, NBIX quarterly EBITDA has changed by -$80.20M (-71.93%)
What is Neurocrine Biosciences TTM EBITDA?
The current TTM EBITDA of NBIX is $559.50M
What is the all time high TTM EBITDA for Neurocrine Biosciences?
Neurocrine Biosciences all-time high TTM EBITDA is $639.70M
What is Neurocrine Biosciences TTM EBITDA year-on-year change?
Over the past year, NBIX TTM EBITDA has changed by +$66.60M (+13.51%)